SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-032384
Filing Date
2024-03-08
Accepted
2024-03-08 16:05:42
Documents
16
Period of Report
2024-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248331d1_8k.htm   iXBRL 8-K 29578
2 EXHIBIT 99.1 tm248331d1_ex99-1.htm EX-99.1 9964
6 GRAPHIC tm248331d1_ex99-1img001.jpg GRAPHIC 10596
  Complete submission text file 0001104659-24-032384.txt   232435

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sls-20240306.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20240306_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20240306_pre.xml EX-101.PRE 22378
17 EXTRACTED XBRL INSTANCE DOCUMENT tm248331d1_8k_htm.xml XML 3619
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 24734323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)